Ephemeral $9.4 Million Stem Cell Deal: Bluebird Bio and California Stem Cell Agency
A $9.4 million deal between a Massachusetts biotech firm and the California stem cell agency has quietly collapsed, raising questions about whether the firm will fulfill its promise to open facilities and hire people in the Golden State.
The company is bluebird bio (the company prefers the lower case spelling) of Cambridge, Mass., which was acclaimed for…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.